| Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
group | 0.100 | None | 0.964 | 28 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta | 0.322 | 0.885 | 1.00 |
|
group | 0.100 | None | 0.963 | 27 | 0 | 2001 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma | 0.320 | 0.885 | 1.4E-06 |
|
group | 0.100 | None | 0.963 | 27 | 0 | 2001 | 2020 | ||||||||
|
MYD88 innate immune signal transduction adaptor | 0.414 | 0.923 | 0.12 |
|
group | 0.500 | None | 1.000 | 26 | 1 | 2011 | 2019 | ||||||||
|
interleukin 2 | 0.336 | 0.885 | 0.48 |
|
group | 0.100 | None | 1.000 | 24 | 0 | 1983 | 2019 | ||||||||
|
microRNA 155 | 0.384 | 0.885 |
|
group | 0.100 | None | 0.957 | 23 | 0 | 2007 | 2019 | |||||||||
|
BMI1 proto-oncogene, polycomb ring finger | 0.448 | 0.808 | 0.94 |
|
group | 0.100 | None | 0.957 | 23 | 0 | 2001 | 2020 | ||||||||
|
interleukin 6 | 0.248 | 0.962 | 0.32 |
|
group | 0.100 | None | 0.955 | 22 | 0 | 1990 | 2019 | ||||||||
|
ATM serine/threonine kinase | 0.374 | 0.885 | 5.6E-47 |
|
group | 0.900 | strong | 0.955 | 22 | 0 | 1998 | 2020 | ||||||||
|
regulator of telomere elongation helicase 1 | 0.459 | 0.808 | 8.9E-10 |
|
group | 0.200 | None | 1.000 | 21 | 1 | 1991 | 2019 | ||||||||
|
BCL10 immune signaling adaptor | 0.491 | 0.769 | 0.34 |
|
group | 0.200 | None | 0.952 | 21 | 0 | 1998 | 2012 | ||||||||
|
TBC1 domain family member 9 | 0.399 | 0.846 | 2.8E-05 |
|
group | 0.100 | None | 0.950 | 20 | 0 | 1989 | 2013 | ||||||||
|
activation induced cytidine deaminase | 0.463 | 0.885 | 9.2E-06 |
|
group | 0.100 | None | 1.000 | 19 | 0 | 2003 | 2018 | ||||||||
|
membrane metalloendopeptidase | 0.407 | 0.808 | 1.5E-18 |
|
group | 0.100 | None | 1.000 | 18 | 0 | 1986 | 2019 | ||||||||
|
nuclear factor kappa B subunit 1 | 0.396 | 0.923 | 1.00 |
|
group | 0.200 | None | 0.882 | 17 | 1 | 1989 | 2020 | ||||||||
|
Bruton tyrosine kinase | 0.464 | 0.808 | 1.00 |
|
group | 0.100 | None | 0.941 | 17 | 0 | 1996 | 2019 | ||||||||
|
cyclin dependent kinase inhibitor 1B | 0.409 | 0.769 | 0.62 |
|
group | 0.100 | None | 0.938 | 16 | 0 | 1997 | 2009 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
group | 0.400 | strong | 1.000 | 16 | 0 | 1995 | 2016 | ||||||||
|
immunoglobulin heavy variable 4-38-2-like | 0.514 | 0.769 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1992 | 2019 | |||||||||
|
AKT serine/threonine kinase 1 | 0.311 | 0.962 | 0.98 |
|
group | 0.100 | None | 0.933 | 15 | 0 | 2005 | 2019 | ||||||||
|
interferon regulatory factor 4 | 0.491 | 0.769 | 0.86 |
|
group | 0.100 | None | 0.933 | 15 | 0 | 2000 | 2019 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
group | 0.400 | None | 1.000 | 15 | 0 | 1998 | 2019 | ||||||||
|
T cell leukemia/lymphoma 1A | 0.558 | 0.500 | 5.7E-10 |
|
group | 0.100 | None | 1.000 | 15 | 0 | 1994 | 2016 | ||||||||
|
tripartite motif containing 13 | 0.462 | 0.846 | 0.64 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 2017 | 2019 | ||||||||
|
putative V-set and immunoglobulin domain-containing-like protein IGHV4OR15-8 | 0.527 | 0.769 |
|
group | 0.100 | None | 1.000 | 14 | 0 | 1997 | 2019 |